The effect of hypothalamic involvement and growth hormone treatment on cardiovascular risk factors during the transition period in patients with childhood-onset craniopharyngioma

키워드

참고문헌 (39)

1. Makino K, "Population-based epidemiological study of primary intracranial tumors in childhood", Childs Nerv Syst, 26, pp.1029~1034 (2010)
2. Ostrom QT, "CBTRUS Statistical Report : primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015", Neuro Oncol, 20(suppl_4), pp.iv1~iv86 (2018)
3. Muller HL, "Craniopharyngioma", Nat Rev Dis Primers, 5, pp.75~ (2019)
4. Erfurth EM, "Mortality and morbidity in adult craniopharyngioma", Pituitary, 16, pp.46~55 (2013)
5. Jung HW, "Correction : autonomic dysfunction is associated with increased cardiometabolic risk in patients with childhoodonset craniopharyngioma", Horm Metab Res, 52, pp.e2~ (2020)
6. Verhelst J, "Prevalence and characteristics of the metabolic syndrome in 2479hypopituitary patients with adult-onset GH deficiency before GH replacement : a KIMS analysis", Eur J Endocrinol, 165, pp.881~889 (2011)
7. de Vile CJ, "Obesity in childhood craniopharyngioma : relation to post-operative hypothalamic damage shown by magnetic resonance imaging", J Clin Endocrinol Metab, 81, pp.2734~2737 (1996)
8. Muller HL, "Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma", J Clin Endocrinol Metab, 89, pp.3298~3305 (2004)
9. Park SW, "Tumor origin and growth pattern at diagnosis and surgical hypothalamic damage predict obesity in pediatric craniopharyngioma", J Neurooncol, 113, pp.417~424 (2013)
10. Holmer H, "Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy", Eur J Endocrinol, 161, pp.671~679 (2009)
11. Kohno H, "Beneficial effect of growth hormone on atherogenic risk in children with growth hormone deficiency", J Pediatr, 126, pp.953~955 (1995)
12. Ahmid M, "Growth hormone deficiency during young adulthood and the benefits of growth hormone replacement", Endocr Connect, 5, pp.R1~R11 (2016)
13. Feinberg MS, "Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age", Am Heart J, 145, pp.549~553 (2003)
14. Gotherstrom G, "A prospective study of 5 years of GH replacement therapy in GH-deficient adults : sustained effects on body composition, bone mass, and metabolic indices", J Clin Endocrinol Metab, 86, pp.4657~4665 (2001)
15. Attanasio AF, "Continued growth hormone(GH)treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients", J Clin Endocrinol Metab, 89, pp.4857~4862 (2004)
16. Carroll PV, "Comparison of continuation or cessation of growth hormone(GH)therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth", J Clin Endocrinol Metab, 89, pp.3890~3895 (2004)
17. Koltowska-Haggstrom M, "Discontinuation of growth hormone(GH)treatment during the transition phase is an important factor determining the phenotype of young adults with nonidiopathic childhood-onset GH deficiency", J Clin Endocrinol Metab, 95, pp.2646~2654 (2010)
18. 김자혜, "Efficacy of growth hormone therapy in adults with childhood-onset growth hormone deficiency", Annals of Pediatric Endocrinology & Metabolism, 19(1), pp.32~35 (2014), 대한소아내분비학회
19. Puget S, "Pediatric craniopharyngiomas : classification and treatment according to the degree of hypothalamic involvement", J Neurosurg, 106(1 Suppl), pp.3~12 (2007)
20. 김재현, "The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects", Clinical and Experimental Pediatrics, 61(5), pp.135~149 (2018), 대한소아청소년과학회
21. World Health Organization. Western Pacific Region, "The Asia-Pacific perspective : redefining obesity and its treatment" (2000), Health Communications Australia
22. 문진수, "2007 한국 소아 청소년 성장도표 : 개발 과정과 전망", Clinical and Experimental Pediatrics, 51(1), pp.1~25 (2008), 대한소아청소년과학회
23. Zimmet P, "The metabolic syndrome in children and adolescents-an IDF consensus report", Pediatr Diabetes, 8, pp.299~306 (2007)
24. Wijnen M, "The metabolic syndrome and its components in 178 patients treated for craniopharyngioma after 16 years of follow-up", Eur J Endocrinol, 178, pp.11~22 (2018)
25. 채지운, "Trends and Risk Factors of Metabolic Syndrome among Korean Adolescents, 2007 to 2018", Diabetes and Metabolism Journal, 45(6), pp.880~889 (2021), 대한당뇨병학회[DOI]
26. Srinivasan S, "Features of the metabolic syndrome after childhood craniopharyngioma", J Clin Endocrinol Metab, 89, pp.81~86 (2004)
27. Sahakitrungruang T, "Obesity, metabolic syndrome, and insulin dynamics in children after craniopharyngioma surgery", Eur J Pediatr, 170, pp.763~769 (2011)
28. Lustig RH, "Hypothalamic obesity after craniopharyngioma : mechanisms, diagnosis, and treatment", Front Endocrinol(Lausanne), 2, pp.60~ (2011)
29. De Vile CJ, "Management of childhood craniopharyngioma : can the morbidity of radical surgery be predicted?", J Neurosurg, 85, pp.73~81 (1996)
30. Mallucci C, "Management of craniopharyngioma : the Liverpool experience following the introduction of the CCLG guidelines. Introducing a new risk assessment grading system", Childs Nerv Syst, 28, pp.1181~1192 (2012)
31. Maison P, "Impact of growth hormone(GH)treatment on cardiovascular risk factors in GH-deficient adults : a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials", J Clin Endocrinol Metab, 89, pp.2192~2199 (2004)
32. Kopchick JJ, "The effects of growth hormone on adipose tissue : old observations, new mechanisms", Nat Rev Endocrinol, 16, pp.135~146 (2020)
33. Angelin B, "Growth hormone and hepatic lipoprotein metabolism", Curr Opin Lipidol, 5, pp.160~165 (1994)
34. Parini P, "Growth hormone specifically stimulates the expression of low density lipoprotein receptors in human hepatoma cells", Endocrinology, 136, pp.3767~3773 (1995)
35. Twickler TB, "Adult-onset growth hormone deficiency : relation of postprandial dyslipidemia to premature atherosclerosis", J Clin Endocrinol Metab, 88, pp.2479~2488 (2003)
36. van der Klaauw AA, "Sustained effects of recombinant GH replacement after 7 years of treatment in adults with GH deficiency", Eur J Endocrinol, 155, pp.701~708 (2006)
37. Goldbourt U, "Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men", Arterioscler Thromb Vasc Biol, 17, pp.107~113 (1997)
38. 최진호, "소아기에 발병한 성장호르몬결핍증 환자의 성인기에서의 재평가 및 성장호르몬 치료: 청소년기에서 성인기로의 이행기의 관리", Annals of Pediatric Endocrinology & Metabolism, 16(1), pp.1~6 (2011), 대한소아내분비학회
39. 김정희, "Diagnosis and Treatment of Growth Hormone Deficiency: A Position Statement from Korean Endocrine Society and Korean Society of Pediatric Endocrinology", Endocrinology and Metabolism, 35(2), pp.272~287 (2020), 대한내분비학회[DOI]

관련 논문AI추천